openPR Logo
Press release

Houston Estate Planning Attorney Whitney L. Thompson Releases Insightful Article on Family LLCs in Estate Plans

04-05-2024 10:32 PM CET | Politics, Law & Society

Press release from: ABNewswire

Houston Estate Planning Attorney Whitney L. Thompson Releases

Houston estate planning attorney Whitney L. Thompson (https://www.wthompsonlaw.com/considerations-for-including-a-family-llc-in-an-estate-plan/), of The Law Office of Whitney L. Thompson, PLLC, has recently published an insightful article detailing the considerations for including a Family Limited Liability Company (LLC) in estate planning. The article sheds light on the strategic advantages of utilizing an LLC as an instrument for estate management and tax minimization.

The Houston estate planning attorney explains the structural benefits of an LLC, which merges characteristics of both partnerships and corporations. This hybrid legal entity not only offers financial management perks but also serves as a robust mechanism for estate planning by enabling assets to be transferred to heirs with reduced tax implications.

According to Houston estate planning attorney Whitney L. Thompson, "A family LLC is not just a tool for asset management; it's a comprehensive strategy to preserve and transfer wealth to the next generation while mitigating the impact of gift and estate taxes." The article recommends consulting with a knowledgeable attorney to tailor an estate plan that incorporates a family LLC, catering to the unique needs of each family.

The article outlines why establishing a family LLC can be pivotal for families. It can provide personal liability protection for its members and streamline the management of assets. Furthermore, for estates exceeding certain financial thresholds, a family LLC can significantly mitigate estate taxes.

Whitney L. Thompson's article sheds light on the structure of a family LLC, where parents typically retain control of the entity, and children or grandchildren hold non-managing shares. This arrangement allows for the distribution of wealth with reduced tax burdens due to the discounted valuation of non-managing members' shares. "By transferring assets into a family LLC and properly managing the distribution of shares, families can benefit from lower taxable values on inheritances," Thompson explains.

The scope of assets transferable into a family LLC is broad, encompassing real estate, cash, and personal possessions. However, understanding the implications of transferring such assets, particularly in the event of an LLC owner's death, is crucial. The article notes that without a clear succession plan, state laws may demand the dissolution of the LLC, underscoring the importance of a well-structured estate plan.

The article clarifies that while an LLC itself generally bypasses the probate process due to its status as a separate legal entity, the ownership interest in the LLC may still necessitate probate if not properly addressed in an estate plan. Thompson advises, "To avoid probate of an LLC interest, individuals should ensure they have a comprehensive estate plan and a solid LLC operating agreement detailing ownership transfer provisions."

The advantages of incorporating a family LLC into an estate plan are multifaceted, with the potential to shield a sizeable portion of an estate from federal taxes and preserve the family legacy. The article also highlights how a family LLC can afford protection against creditors, safeguarding heirs' inheritances.

The article provides a strong recommendation to seek professional legal and financial advice when considering a family LLC. The complexity of this estate planning tool necessitates experienced legal guidance to ensure that it aligns with one's personal and family objectives.

For those looking to explore the integration of a family LLC into their estate plan, the insights provided by Whitney L. Thompson are invaluable. The article serves as a testament to the importance of strategic planning and the potential benefits that a family LLC can offer.

About The Law Office of Whitney L. Thompson, PLLC:

The Law Office of Whitney L. Thompson, PLLC, led by Whitney L. Thompson, is a legal practice dedicated to providing comprehensive estate planning services. The firm's commitment lies in assisting clients in navigating the complexities of asset protection and wealth transfer across generations. With a focus on personalized service, The Law Office of Whitney L. Thompson, PLLC, dedicates itself to ensuring that each client's estate planning goals are met with meticulous attention to detail and adherence to the highest standards of legal practice.

Embeds:

Youtube Video: https://www.youtube.com/watch?v=x6ucL-6jYS8

GMB: https://www.google.com/maps?cid=9428708165305469162

Email and website

Email: info@wthompsonlaw.com

Website: https://www.wthompsonlaw.com/

Media Contact
Company Name: The Law Office of Whitney L. Thompson, PLLC
Contact Person: Whitney L. Thompson
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=houston-estate-planning-attorney-whitney-l-thompson-releases-insightful-article-on-family-llcs-in-estate-plans]
Phone: (281) 214-0173
Address:4201 Farm to Market 1960 Rd W Suite 219, Box #116B
City: Houston
State: Texas 77068
Country: United States
Website: https://www.wthompsonlaw.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Houston Estate Planning Attorney Whitney L. Thompson Releases Insightful Article on Family LLCs in Estate Plans here

News-ID: 3454321 • Views:

More Releases from ABNewswire

Dry Eye Disease Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | AbbVie, Allergan, AFT Pharma, Akorn, Alcon Inc., Bausch Health Companies
Dry Eye Disease Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Dry Eye Disease pipeline constitutes 45+ key companies continuously working towards developing 50+ Dry Eye Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Dry Eye Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also
Relapsed/Refractory Acute Myeloid Leukemia Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Emerging Therapies, Clinical Trials, and Treatment Outlook | Foghorn Therapeutics
Relapsed/Refractory Acute Myeloid Leukemia Pipeline Review, 2024 Updates | Lates …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Relapsed/Refractory Acute Myeloid Leukemia pipeline constitutes 50+ key companies continuously working towards developing 75+ Relapsed/Refractory Acute Myeloid Leukemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Relapsed/Refractory Acute Myeloid Leukemia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase.
Parkinson's Disease Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | AbbVie, Pfizer, Novartis, Roche, Kissei Pharma, AstraZeneca
Parkinson's Disease Pipeline and Clinical Trials Assessment 2024: FDA Approvals, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Parkinson's Disease pipeline constitutes 140+ key companies continuously working towards developing 150+ Parkinson's Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Parkinson's Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed
CTLA-4 Inhibitors Competitive Landscape and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Henlix Biotech, Harbour BioMed, AstraZeneca, Innovent
CTLA-4 Inhibitors Competitive Landscape and Clinical Trials Assessment 2024: FDA …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, CTLA-4 Inhibitors Competitive Landscape constitutes 40+ key companies continuously working towards developing 50+ CTLA-4 inhibitors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The CTLA-4 Inhibitors Competitive Landscape report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers

All 5 Releases


More Releases for Thompson

Thompson & Knight Opens LA Office
The law firm of Thompson & Knight LLP is pleased to announce the opening of its newest office in Los Angeles, California. The Firm has landed noted litigator Bruce J. Zabarauskas, who joins Thompson & Knight Partner, Shelly A. Youree, to launch operations. Opening October 1, 2012, the new office will be located in Century City at 10100 Santa Monica Boulevard, Suite 950, Los Angeles, California 90067. “The opening
Matthew Thompson Joins Jackson Walker
Jackson Walker is pleased to welcome new partner Matthew Thompson to the firm. Mr. Thompson concentrates his practice on advanced U.S. immigration and nationality law and global business immigration matters, assisting employers with immigration challenges facing international workforces. He has extensive experience in all areas of U.S. immigration law, but primarily focuses his current practice on employment-based immigration for corporate clients, naturalization, and the immigration practices and regulations for foreign
Thompson & Knight Expands Trial Practice
Dallas (August 15, 2011) – The global law firm of Thompson & Knight LLP is pleased to announce that Nathan H. Aduddell* has joined the Firm’s Trial Department as an Associate in the Dallas office. “Nathan comes to us with an excellent record of scholastic achievement and success in trial-related competitions, all accomplishments we believe will enhance his trial skills. We are very pleased to have him join
Thompson & Knight’s 2008 New Associates
Texas (October 22, 2008) - The global law firm of Thompson & Knight LLP is pleased to announce the addition of 18 new associates in its Austin, Dallas, and Houston offices. Austin Office Jon Schnautz* joined the Firm’s Trial Practice Group in Austin. He received a J.D., with high honors, from The University of Texas School of Law in 2008 and a Bachelor of Journalism, summa cum laude, from The University
Thompson & Knight Expands Tax Practice
HOUSTON – The global law firm of Thompson & Knight LLP is pleased to announce Roger D. Aksamit has joined the Firm as a Partner in the Tax Practice Group of the Firm’s Houston office. He brings more than 25 years of legal experience to Thompson & Knight. “We are thrilled to have Roger join the Firm,” says Pete Riley, Managing Partner of the Firm. “Houston\'s energy economy
Thompson & Knight Expands Trial Practice
The global law firm of Thompson & Knight LLP is pleased to announce the continued expansion of its Trial Practice Group with the addition of Associates Victor Arturo Arana and Gabrielle E. Farina. Arana is resident in the Firm’s Austin office, and Farina is resident in the Firm’s New York office. “Victor and Gabrielle are great additions to our Firm, and we are delighted to have them join us.